CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer ModelsHuizhong Li, Qing Zhang, Jiage Ding et al.|Journal of Immunotherapy|2019Cited by 97
Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.Qing Zhang, Junnian Zheng, Mengmeng Lü et al.|PubMed|2019Cited by 44
Bortezomib improves adoptive carbonic anhydrase�IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinomaQing Zhang, Junnian Zheng, Jǐnjīng Xǔ et al.|Oncology Reports|2018Cited by 29
Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimensJǐnjīng Xǔ, Junnian Zheng, Kang Tian et al.|Expert Review of Anticancer Therapy|2017Cited by 22
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive ImmunityHongyan Liu, Qing Zhang, Shishuo Sun et al.|Frontiers in Oncology|2021Cited by 20